Ownership history in RIVERBRIDGE PARTNERS LLC · 35 quarters on record
This page tracks every 13F SEC filing in which RIVERBRIDGE PARTNERS LLC reported a position in West Pharmaceutical Services, (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 318,613 | -43,927 | -12.1% | 1.64% | $87.7M | $274.89 |
| 2025 Q3 | REDUCED | 362,540 | -20,980 | -5.5% | 1.60% | $95.1M | $261.88 |
| 2025 Q2 | REDUCED | 383,520 | -24,886 | -6.1% | 1.35% | $83.9M | $218.25 |
| 2025 Q1 | REDUCED | 408,406 | -26,887 | -6.2% | 1.47% | $91.4M | $223.09 |
| 2024 Q4 | REDUCED | 435,293 | -21,456 | -4.7% | 1.95% | $142.6M | $326.20 |
| 2024 Q3 | REDUCED | 456,749 | -30,187 | -6.2% | 1.83% | $137.1M | $298.72 |
| 2024 Q2 | REDUCED | 486,936 | -14,955 | -3.0% | 2.18% | $160.4M | $327.59 |
| 2024 Q1 | ADDED | 501,891 | +32,646 | +7.0% | 2.42% | $198.6M | $393.34 |
| 2023 Q4 | REDUCED | 469,245 | -8,295 | -1.7% | 2.20% | $165.2M | $349.82 |
| 2023 Q3 | REDUCED | 477,540 | -85,963 | -15.3% | 2.60% | $179.2M | $372.54 |
As of 2025 Q4 — sorted by position size